Skip to main content
. 2021 Apr 16;2021(4):CD010682. doi: 10.1002/14651858.CD010682.pub3

Comparison 3. RCT: venlafaxine versus no treatment controls.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 > 50% reduction in depressive symptoms 1 64 Risk Ratio (M‐H, Fixed, 95% CI) 3.25 [1.19, 8.90]
3.2 Mean depression scores ‐ HAMD 1 64 Mean Difference (IV, Fixed, 95% CI) ‐7.59 [‐11.52, ‐3.66]